ASCO '13: Amgen's Cancer-Killing Virus Shows Skin-Cancer Survival Trend
TheStreet.com
PD-1 refers to the drugs being developed by Bristol-Myers, Merck and Roche. "We're doing early safety studies, it's too early to comment but the interest in pursuing this approach is much higher today." In the Amgen phase III trial, more than 400 ...
http://www.thestreet.com/story/11938587/1/asco-13-amgens-cancer-killing-virus-shows-skin-cancer-survival-trend.html?cm_ven=GOOGLEN
by world drug tracker
DR ANTHONY MELVIN CRASTO
TheStreet.com
PD-1 refers to the drugs being developed by Bristol-Myers, Merck and Roche. "We're doing early safety studies, it's too early to comment but the interest in pursuing this approach is much higher today." In the Amgen phase III trial, more than 400 ...
http://www.thestreet.com/story/11938587/1/asco-13-amgens-cancer-killing-virus-shows-skin-cancer-survival-trend.html?cm_ven=GOOGLEN
by world drug tracker
DR ANTHONY MELVIN CRASTO
No comments:
Post a Comment